Amundi Core MSCI China A Swap -UCITS ETF USD- DistributionAmundi Core MSCI China A Swap -UCITS ETF USD- DistributionAmundi Core MSCI China A Swap -UCITS ETF USD- Distribution

Amundi Core MSCI China A Swap -UCITS ETF USD- Distribution

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪474.45 M‬EUR
Fund flows (1Y)
‪105.04 M‬EUR
Dividend yield (indicated)
1.74%
Discount/Premium to NAV
−0.3%
Shares outstanding
‪2.60 M‬
Expense ratio
0.40%

About Amundi Core MSCI China A Swap -UCITS ETF USD- Distribution


Issuer
SAS Rue la Boétie
Brand
Amundi
Inception date
Mar 10, 2023
Structure
Luxembourg SICAV
Index tracked
MSCI China A
Replication method
Synthetic
Management style
Passive
Dividend treatment
Distributes
Primary advisor
Amundi Luxembourg SA
ISIN
LU2572256746
The objective of this SubFund is to track the performance of MSCI China A Index

Classification


Asset Class
Equity
Category
Size and style
Focus
Total market
Niche
Broad-based
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of November 7, 2025
Exposure type
Stocks
Health Technology
Technology Services
Retail Trade
Stocks100.00%
Health Technology16.20%
Technology Services13.47%
Retail Trade12.47%
Electronic Technology9.33%
Finance8.67%
Health Services7.66%
Producer Manufacturing6.86%
Process Industries5.81%
Industrial Services5.07%
Consumer Durables4.23%
Transportation3.63%
Consumer Non-Durables3.46%
Consumer Services1.99%
Utilities0.78%
Non-Energy Minerals0.27%
Energy Minerals0.06%
Commercial Services0.04%
Bonds, Cash & Other0.00%
Stock breakdown by region
94%5%
North America94.79%
Europe5.21%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


C024 invests in stocks. The fund's major sectors are Health Technology, with 16.20% stocks, and Technology Services, with 13.47% of the basket. The assets are mostly located in the North America region.
C024 top holdings are NVIDIA Corporation and UnitedHealth Group Incorporated, occupying 8.08% and 7.66% of the portfolio correspondingly.
C024 last dividends amounted to 3.03 EUR. The year before, the issuer paid 2.27 EUR in dividends, which shows a 24.94% increase.
C024 assets under management is ‪474.45 M‬ EUR. It's fallen 4.85% over the last month.
C024 fund flows account for ‪105.04 M‬ EUR (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, C024 pays dividends to its holders with the dividend yield of 1.74%. The last dividend (Dec 12, 2024) amounted to 3.03 EUR. The dividends are paid annually.
C024 shares are issued by SAS Rue la Boétie under the brand Amundi. The ETF was launched on Mar 10, 2023, and its management style is Passive.
C024 expense ratio is 0.40% meaning you'd have to pay 0.40% of your investment to help manage the fund.
C024 follows the MSCI China A. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
C024 invests in stocks.
C024 price has risen by 1.37% over the last month, and its yearly performance shows a 8.97% increase. See more dynamics on C024 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 2.88% over the last month, showed a 17.76% increase in three-month performance and has increased by 12.59% in a year.
C024 trades at a premium (0.28%) meaning the ETF is trading at a higher price than the calculated NAV.